Pathology News

Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School  Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive. ...

OptraSCAN was recently recognized by Frost and Sullivan with a Global Telepathology Enabling Technology Leadership Award. And why shouldn't they be recognized -- I think they are hitting on one of the key market segments that is largely...

“Crosswalk Insight™: Oncology” enhances Inspirata’s Digital Pathology Cockpit by providing access to Genomic Profiles, FDA-Approved Targeted Therapies, Immunotherapies and Clinical Trials to enable pathologists to make more precise...

Download PDF of Recommendations The Washington Post (9/7, McGinley) highlights a report released by a “blue-ribbon panel” of “top cancer researchers and patient advocates” as part of the White House’s cancer moonshot. The report...

Last Fall I wrote a couple of posts about the growing disenchantment with 'Pinkification' and 'Pinktober' referencing the all-out blitz during October to go "Pink" for breast bancer awareness and prevention.  In one of the pieces I mentioned...

Science, health care and technology conglomerate Danaher Corp. DHR 0.28 % said Tuesday that it would buy molecular-diagnostics company Cepheid Inc. CPHD -0.20 % for $53.00 a share, in its first major acquisition since spinning off a...